ALDH1A1 and ALDH3A1 Expression of Melanocytic Neoplasms and Associated with Clinicopathological Parameters in Chinese People

Ching-Fu Huang ； Hong-Wei Gao ； Wen-Chiuan Tsai ； Bai-Yao Wu ； Wei-Ming Wang ； Fang-Yih Liaw ； Chien-Ping ； Chiang

《Journal of Medical Sciences》 33卷6期 (2013/12) Pp. 333-340

https://doi.org/10.6136/JMS.2013.33(6).333

並列摘要

Background: ALDH1A1 and ALDH3A1 were reported to be highly expressed in some cancerous tissues. The aim of this study was to assess ALDH1A1 and ALDH3A1 expression and cellular localization in a spectrum of melanocytic lesions, ranging from common melanocytic nevi (CMN) and dysplastic nevi (DN) to acral melanoma (AM). We also compared the clinicopathological correlation of AM in a large Chinese population. Material and Methods: We used purified classspecific antibodies against ALDH1A1 and ALDH3A1 to elucidate the cellular distribution of these proteins in a human tissue microarray derived from 20 patients with CMN, 12 patients with DN, and 80 patients with primary acral MM. The cytoplasmic immunostaining score was obtained by multiplying the percentage of antigen-positive cells by their average immunostaining intensity. Mean ± S.E.M. for each experimental group was calculated and compared. The relationships between AJCC TNM stage and cytoplasmic scores of ALDH1A1 and ALDH3A1 were examined. Results: A statistically higher score for ALDH1A1 staining was noted in CMN than in DN (p＜0.028). ALDH3A1 staining was significantly different between CMN and AM. No statistical differences in survival and no association between cytoplasmic staining of both enzymes and other clinical parameters were demonstrated. Conclusion: ALDH1A1 and ALDH3A1 were differentially expressed in CMN, DN, and AM; yet, these enzymes may not be appropriate for use as prognostic factors.

並列關鍵字

ALDH1A1 ； ALDH3A1 ； melanocytic neoplasms

參考文獻

Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Overcoming apoptosis deficiency of melanoma- hope for new therapeutic approaches. Drug Resist Updat 2007;10:218-234.

Warburg, O. On the origin of cancer cells. Science 1956;123:309-314.

Sheng H, Niu B, Sun H. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies. Curr Med Chem 2009;16:1561-1587.

Amann PM, Hofmann C, Freudenberger M, Holland- Cunz S, Eichmüller SB, Bazhin AV. Expression and activity of alcohol and aldehyde dehydrogenases in melanoma cells and in melanocytes. J Cell Biochem 2012;113:792-799, doi: 10.1002/jcb.23406.

Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, Roop DR, Vasiliou V, Fujita M. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells 2012;30:2100-2113, doi: 10.1002/stem.1193.